Transfusion audits - Previous audits 2008

Page contents: Clinical Audit of Fresh Frozen Plasma Use | Clinical Audit of Cryoprecipitate Use

Please note: for older audits see Transfusion audits in 2005-06 & Transfusion audits in 2007

Clinical Audit of Cryoprecipitate Use

Cryoprecipitate transfusions are indicated for the prevention and treatment of haemorrhage in patients with fibrinogen deficiency. Previous studies have shown variation in clinical practice in the transfusion of cryoprecipitate.

The level of measured laboratory fibrinogen is the primary indicator for cryoprecipitate transfusion, with the risk of bleeding and the extent of bleeding also used as indicators for transfusion of cryoprecipitate.

Note should be taken of the National Health & Medical Research Council/Australian and New Zealand Society of Blood Transfusion guidelines for transfusion of cryoprecipitate (NH&MRC/ANZSBT, 2001). The NH&MRC/ANZSBT Clinical Practice Guidelines on the Use of Blood Components are available from the National Health and Medical Research Council website.

The Blood Matters Program wishes to work with hospitals to ensure that:

a) blood components and products are used appropriately and effectively, and

b) alternative blood management strategies are used to limit the need for transfusion where clinically appropriate.

The Blood Matters Advisory Committee has identified the area of cryoprecipitate use as an appropriate area for targeted clinical audit in order to determine current practice across the State.

Clinical Audit of Cryoprecipitate Use Information Sheet (56kb, pdf)

Form: Clinical Audit of Cryoprecipitate Use (32kb, pdf)

Data Submission for Cryoprecipitate

Data entry is via the online submission form and is available for entry as of now. A cryo audit data entry guide has been developed to assist with online submission.

Organisations without access to the web can forward hard copy audit forms to:

Blood Matters
Statewide Quality Branch
Department of Human Services
GPO Box 4057
Melbourne 3001

Clinical Audit of Fresh Frozen Plasma Use

Fresh Frozen Plasma (FFP) transfusions are required in certain clinical circumstances to correct coagulation factor deficiency. Previous studies have shown variation in clinical practice in the transfusion of FFP.

The level of measured laboratory coagulation test abnormality is often used as an indicator for FFP transfusion.

Note should be taken of the National Health & Medical Research Council/Australian and New Zealand Society of Blood Transfusion guidelines for transfusion of FFP (NH&MRC/ANZSBT, 2001).

The Blood Matters Program wishes to work with hospitals to ensure that:

a) blood components and products are used appropriately and effectively, and
b) alternative blood management strategies are used to limit the need for transfusion where clinically appropriate.

The Blood Matters Advisory Committee has identified the area of FFP use as an appropriate area for targeted clinical audit in order to determine current practice across the State.

Clinical Audit of Fresh Frozen Plasma Use information sheet - 11 April 2008 (51kb, pdf)

Form: Clinical Audit of Fresh Frozen Plasma Use - 11 April 2008 (33kb, pdf)

Data submission for Fresh Frozen Plasma (FFP)

Data entry is via the online submission form and is available for entry as of now. A FFP audit data entry guide has been developed to assist with online submission.

FFP Audit Data Entry Guide (83kb, pdf)

Organisations experiencing difficulty entering data in this way can contact the Blood Matters secretariat on 03 9096 9037. Organisations without access to the web can forward hard copy audit forms to:

Blood Matters
Statewide Quality Branch
Department of Human Services
GPO Box 4057
Melbourne 3001

top of page